Clinical Experience  

Documenting Results LDR’s reputation escalated as word of its new developments and strong clinical performances in Europe circulated. Demonstrating this strong clinical performance is critical to the ongoing success of LDR’s products.   • Since 2004, a prospective study is ongoing in France that pools data from 10 evaluation centers to assess the safety and efficacy of the Mobi-C in treating cervical degenerative disease. Enrollment is closed, and almost 400 patients will be analyzed over a 10 year follow-up period. Preliminary results have been published in the European Spine Journal (2009). • Since 2003, a similar study is in progress for Mobidisc in treating lumbar degenerative disc disease. 408 patients are being followed-up. • In 2009, a total of 4 studies were initiated in France and the USA to evaluate the safety and efficacy of the ROI-A and ROI-C interbody fusion cages. • In 2006, LDR was the first company to obtain FDA approval to conduct an IDE study for the Mobi-C for both one and two levels in the United States. • LDR is committed to helping surgeons, through national or international publications, to continually inform the worldwide community about our clinical results.

International Training LDR created a well-organized and utilized international training program where interested doctors from all over the world are brought to the experts in their home country. In this hands-on learning environment, the expert surgeon can share their experience and surgical technique with maximum effectiveness. LDR also regularly engages leading surgeons to review clinical results, assess the product performance, and make suggestions on how to improve the surgical techniques.

CAUTION: The Mobi-C™ artificial disc is an Investigational Device and is limited to investigational use in the United States.
The Mobi-L™ (Mobidisc®) is not available in the United States.

Back to Top

Printable Version